Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

EXACT SCIENCES CORP Director's Dealing 2013

Sep 24, 2013

30597_dirs_2013-09-24_f88e7676-49a0-431f-b76c-d00b0a5c916d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: EXACT SCIENCES CORP (EXAS)
CIK: 0001124140
Period of Report: 2013-09-20

Reporting Person: CRAWFORD SALLY (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2013-09-20 Common Stock M 15000 $4.99 Acquired 218866 Direct
2013-09-20 Common Stock M 10000 $2.24 Acquired 228866 Direct
2013-09-20 Common Stock S 25000 $12.19 Disposed 203866 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2013-09-20 Stock Option (right to buy) $4.99 M 15000 Disposed 2014-07-23 Common Stock (15000) Direct
2013-09-20 Stock Option (right to buy) $2.24 M 10000 Disposed 2015-07-22 Common Stock (10000) Direct

Footnotes

F1: These options were issued to Ms. Crawford, who has served as a director of the Company since 1999, as compensation for director service in 2004 and 2005 under the Company's non-employee director compensation policy. The exercise of these options and subsequent sale of common stock reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 27, 2013.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.46 to $12.09, inclusive. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2) to this Form 4.